Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Hagop M. Kantarjian

Toward the Potential Cure of Leukemias in the Next Decade

Cancer

Cancer Research

Oncology

2018

English

Reply to Starting With a Lower Daily Dose of Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase: Less Is More, or Is It?

English

Cancer Research in the United States: A Critical Review of Current Status and Proposal for Alternative Models

English

Adult Acute Lymphoblastic Leukemia

English

Final Results of a Phase 2, Open-Label Study of Indisulam, Idarubicin, and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

English

Hepatitis C: When High Drug Prices Preclude Patient Benefit

English

The Distribution of T-Cell Subsets and the Expression of Immune Checkpoint Receptors and Ligands in Patients With Newly Diagnosed and Relapsed Acute Myeloid Leukemia

English

Efficacy and Safety Analysis by Age Cohort of Inotuzumab Ozogamicin in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Enrolled in INO-VATE

English

Acute Lymphoblastic Leukemia in Adolescents and Young Adults

English

Prognostic Significance of Hyperdiploidy in Adult Acute Myeloid Leukemia

American Journal of Hematology

Hematology

2018

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Hagop M. Kantarjian

Toward the Potential Cure of Leukemias in the Next Decade

Reply to Starting With a Lower Daily Dose of Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase: Less Is More, or Is It?

Cancer Research in the United States: A Critical Review of Current Status and Proposal for Alternative Models

Adult Acute Lymphoblastic Leukemia

Final Results of a Phase 2, Open-Label Study of Indisulam, Idarubicin, and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

Hepatitis C: When High Drug Prices Preclude Patient Benefit

The Distribution of T-Cell Subsets and the Expression of Immune Checkpoint Receptors and Ligands in Patients With Newly Diagnosed and Relapsed Acute Myeloid Leukemia

Efficacy and Safety Analysis by Age Cohort of Inotuzumab Ozogamicin in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Enrolled in INO-VATE

Acute Lymphoblastic Leukemia in Adolescents and Young Adults

Prognostic Significance of Hyperdiploidy in Adult Acute Myeloid Leukemia